ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Clinical Scientist at AbCellera - ApplyBlast

Senior Clinical Scientist

AbCellera

2 days ago

3.6 on Glassdoor

Vancouver, British Columbia, Canada

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Clinical Scientist drives early-phase clinical development in oncology and endocrinology, integrating preclinical findings into clinical strategies and designing Phase 1-2 trials. The role involves authoring clinical study protocols and regulatory filings, executing early-phase studies, and delivering proof-of-concept for novel drug candidates. This position requires collaboration with cross-functional teams to ensure scientific rigor and operational feasibility throughout the study cycle.

Responsibilities

Design and execute Phase 1-2 clinical trials in oncology and endocrinology
Author clinical study protocols and regulatory filings for global submissions
Integrate preclinical findings into clinical strategies and drive proof-of-concept

Skills

Qualifications

Ph.D.PharmDM.S. in Life SciencesMD

About AbCellera

abcellera.com

Headquarters

Vancouver, British Columbia, Canada

Company Size

501-1000 employees

Founded

2012

View Profile

AbCellera is a biotechnology company that discovers and develops therapeutic antibodies using a proprietary high-throughput single‑cell screening platform combined with machine learning and large immune datasets. It partners with pharma and biotech to rapidly identify and optimize antibody leads and also advances its own pipeline of first‑in‑class and best‑in‑class programs across multiple indications and modalities. The platform is designed to accelerate target‑to‑candidate timelines and has been used in rapid-response collaborations and clinical‑stage antibody programs.